WS #10413

11:56→12:22 UTC

From 500 msgs · 5 key-dev

AbbVie to buy Apogee for $135.11/share cash (~$10.9B, ~60% premium), adding IL-13 asset APG777; APGE jumps 52% premarket.

AbbVie Acquires Apogee Therapeutics

AbbVie to buy Apogee for $135.11/share cash (~$10.9B, ~60% premium), adding IL-13 asset APG777; APGE jumps 52% premarket.